Patent Issued for Glycotargeting therapeutics (USPTO 11801305)

MLA

“Patent Issued for Glycotargeting Therapeutics (USPTO 11801305).” Obesity, Fitness & Wellness Week, Nov. 2023, p. 994. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.773351932&authtype=sso&custid=ns315887.

APA

Patent Issued for Glycotargeting therapeutics (USPTO 11801305). (2023, November 25). Obesity, Fitness & Wellness Week, 994.

Chicago

Obesity, Fitness & Wellness Week. 2023. “Patent Issued for Glycotargeting Therapeutics (USPTO 11801305),” November 25. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.773351932&authtype=sso&custid=ns315887.